Novadaq (NVDQ) Prelim. Q4, FY13 Revs Outpace Expectations

Novadaq Technologies Inc. (Nasdaq: NVDQ) announces preliminary unaudited revenue for the fourth quarter 2013 of approximately $10.7 million, bringing expected full year 2013 revenues to approximately $35.0 million. The preliminary unaudited quarterly numbers have not gone through review and audit procedures by the Company's external auditors and may differ from actual revenues. The Street sees Q4 revs of $10.2 million and FY13 revs of $34.4 million. The preliminary unaudited revenues in the fourth quarter of 2013 reflect an increase of approximately 57% versus revenues of $6.8 million in the fourth quarter of 2012, and the preliminary unaudited revenues for all of 2013 reflect an increase of approximately 52% versus revenues of $23 million in 2012. Growth was driven by increases in the number of patients treated using Novadaq's imaging technologies, and increases in capital sales of our devices. The Company is providing the preliminary unaudited revenues for 2013 in advance of its first presentation at the J.P. Morgan Healthcare Conference, where President and Chief Executive Officer, Dr. Arun Menawat will speak at 9:30 am Pacific Time on January 14, 2014.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Rackspace cuts FY26 revenue outlook by $150M, expands AI plans
• ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half
• AeroVironment sets fiscal year 2030 revenue target of $3.5B-$4B